Skip to main content
Profound Medical Corp. logo

Profound Medical Corp. — Investor Relations & Filings

Ticker · PROF ISIN · CA74319B5027 US Manufacturing
Open in API
Filings indexed 260 across all filing types
Latest filing 2022-02-10 Regulatory Filings
Country US United States of America
Listing US PROF

About Profound Medical Corp.

https://profoundmedical.com/

Profound Medical Corp. is a commercial-stage medical technology company that develops and markets incision-free therapies for ablative interventions. The company's primary platform, TULSA-PRO®, combines real-time Magnetic Resonance (MR) imaging with robotically-driven, transurethral thermal ultrasound and closed-loop temperature feedback. This system is designed for the precise and customizable ablation of prostate tissue from the inside-out. It is used to treat various conditions, including localized prostate cancer and benign prostatic hyperplasia (BPH). The technology enables physicians to create customized treatment plans and monitor tissue temperature in real-time, aiming to maximize efficacy while preserving patient quality of life.

Recent filings

Filing Released Lang Actions
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Profound Medical Corp., pursuant to SEC rules. It is a regulatory filing that includes a press release as an exhibit. The document length is short (1464 characters), and it primarily serves as a report submission rather than containing detailed financial data or a full report. According to the rules, Form 6-K filings are considered Regulatory Filings (RNS) as they are miscellaneous filings that do not fit into other specific categories and often include updates or press releases. Therefore, the appropriate classification is Regulatory Filings (RNS).
2022-02-10 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-02-09 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Profound Medical Corp., pursuant to SEC rules. It includes an exhibit index referencing a press release dated February 8, 2022. The document length is short (1462 characters) and primarily serves as a cover report for the attached press release. There is no substantive financial data or detailed report content within this text. According to the 'Menu vs Meal' rule, this is an announcement of a report (the press release) rather than the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2022-02-08 English
SC 13G/A
Major Shareholding Notification
2022-02-03 English
SC 13G/A
Major Shareholding Notification
2022-02-03 English
FORM 6-K
Regulatory Filings Classification · 100% confidence The document is a Form 6-K, which is a report of a foreign private issuer submitted pursuant to SEC rules. It includes an exhibit index referencing a press release dated January 18, 2022. The document length is only 1461 characters, indicating it is a short filing primarily serving as a cover or notification rather than a full report. There is no substantive financial data or detailed report content present. According to the rules, such short filings that announce or attach other documents are classified as Regulatory Filings (RNS).
2022-01-18 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.